BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1464496)

  • 1. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI.
    Berkowitz BA; Tofts PS; Sen HA; Ando N; de Juan E
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3500-6. PubMed ID: 1464496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
    Berkowitz BA; Sato Y; Wilson CA; de Juan E
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of breakdown of the inner and outer blood-retinal barriers.
    Sen HA; Berkowitz BA; Ando N; de Juan E
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3507-12. PubMed ID: 1464497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier.
    Plehwe WE; McRobbie DW; Lerski RA; Kohner EM
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):663-70. PubMed ID: 3366561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis.
    Metrikin DC; Wilson CA; Berkowitz BA; Lam MK; Wood GK; Peshock RM
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1361-70. PubMed ID: 7775114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR molecular imaging of early endothelial activation in focal ischemia.
    Barber PA; Foniok T; Kirk D; Buchan AM; Laurent S; Boutry S; Muller RN; Hoyte L; Tomanek B; Tuor UI
    Ann Neurol; 2004 Jul; 56(1):116-20. PubMed ID: 15236408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
    Hashimoto K; Yamagata S; Minamikawa J; Watanabe Y; Kanesiro M; Kikuchi H
    No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images.
    Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S
    Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gd-DTPA in the diagnosis of brain metastasis].
    Kornienko VN; Pronin IN
    Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P; Montanari N; De Santis M; Pollastri C
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D MRI of the cervical spine: low flip angle FISP vs. Gd-DTPA TurboFLASH in degenerative disk disease.
    Ross JS; Ruggieri PM; Glicklich M; Obuchowski N; Dillinger J; Masaryk TJ; Qu Y; Modic MT
    J Comput Assist Tomogr; 1993; 17(1):26-33. PubMed ID: 8419435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced MRI.
    Berkowitz BA; Wilson CA; Tofts PS; Peshock RM
    Magn Reson Med; 1994 Jan; 31(1):61-6. PubMed ID: 8121271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats.
    Berkowitz BA; Roberts R; Luan H; Peysakhov J; Mao X; Thomas KA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2391-8. PubMed ID: 15223822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of acute cerebral infarction: experimental study with Gd-DTPA.
    Hayakawa K; Yamashita K; Matsuda T; Miyake T; Ito H
    Radiat Med; 1989; 7(2):58-65. PubMed ID: 2798931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.